WITN3953031 - Interim Clinical Commissioning policy statement entitled Sofosbuvir DeclatasvirLedipasvir - Ribivirin for defined patients with Hepatitis C - 19 Apr 2014
NHS England Interim Clinical Commissioning policy statement Sofosbuvir + Declatasvir-Ledipasvir +-- Ribivirin for defined patients with Hepatitis C
Documents
WITN3953031 Interim Clinical Commissioning policy statement entitled Sofosbuvir DeclatasvirLedipasvir Ribivirin for defined patients with Hepatitis C 19 Apr 2014